The aim of this study was to evaluate hepatic vaspin mRNA in morbidly obese womenwithnonalcoholicfattyliverdisease(NAFLD)andtolookforitsrelationshipswithmetabolicandhistopathologicalfeatures. Thestudyincluded56severelyobesewomenwhounderwentintraoperativewedge liverbiopsyduringbariatricsurgery.HepaticvaspinmRNAwasassessedbyquantitativereal-timePCR. VaspinmRNAfoundinallincludedpatientswasmarkedlyhigherinpatientswith bodymassindex(BMI)≥40kg/m 2 (4.59±3.09vs.0.44±0.33;p=0.05).An evident but statistically insignificant difference in vaspin mRNA levels was observedbetweenpatientswithandwithouthepatocyteballooning(4.77±4.23vs. 0.45±0.29,respectively),withandwithoutsteatosis(4.80±4.20vs.0.41±0.29, respectively),withoutandwithfibrosis(0.25±0.80vs.6.23±7.2,respectively), andthosewithoutandwithlobularinflammation(0.27±1.0vs.5.55±10.1,respectively).TherewasmarkeddifferenceinvaspinmRNAbetweenpatientswith simplesteatosis/borderlinenonalcoholicsteatohepatitis(NASH)comparedtothose withdefiniteNASH(0.24±0.96vs.10.5±10.4). Adiposity is an undoubted confounding factor influencing vaspin levels. Hepatic vaspinmRNAseemstobemarkedlyelevatedinmorbidlyobesepatientswithmore advancedNAFLDandwhenhallmarksofNASHwereobserved.Pointingtonon-linearmRNAlevelswithintheNAFLDspectrumandanevidentincreaseinpatients withfibrosisanddefiniteNASH,thedetrimentalactionofvaspincannotbeexcluded.
Introduction
An alarming increase in the rate of obesity and nonalcoholic fatty liver disease (NAFLD) has been observed recently, particularly in developed countries.TheprevalenceofNAFLDisestimatedinthe generalpopulationofwesterncountriestobegreaterthan30%,achieving67%-75%inobese [1] and 75-95% in morbidly obese patients [2] . The prevalence of nonalcoholic steatohepatitis (NASH) reaches 20-54% [3, 4] . NASH-related cirrhosis hasbecomethesecond-leadingdiseaseamongliver transplant waitlist registrants in the United States [5] . Increased triglyceride accumulation in hepatocytesleadstohepaticsteatosis,whichmayprogress to NASH, cirrhosis, or hepatocellular carcinoma (HCC) [6, 7] . The rate of progression from simple steatosistomoreadvancedstagesofNAFLDhasnot been well defined. It has been known that 7-37% ofpatientswithNASHhaveconcomitantadvanced fibrosis and the tendency for progression to cirrhosis [8, 9] . Pathogenesis of NAFLD and NASH is multifactorial and multiple. Various factors have beensuggestedtoleadtodiseasedevelopmentand progression.EssentialforNAFLDoccurrencearedietaryfactors,insulinresistance(IR),andadipokines [10, 11, 12] . Genetic, immune, and endocrine factors,alongsidegutmicrobiotaandHelicobacter pylori, should also be considered [13, 14, 15] . Consequently,therecognitionofaphenomenonleadingto progression from benign fatty liver to NASH with severefibrosisisofcrucialimportance.Thesearchfor markersofthisprogressionhassubstantialmeaning forclinicalproceeding.Manyfactorslikecytokines, adipokines,andadhesivemoleculesareconsideredas the factors participating in the progression of liver injuryinNAFLD [12, 16, 17, 18] .However,therole ofthesefactorsinthedevelopmentofliverdamage, aswellasthepracticalutilityasdiagnosticmarkers, hasnotbeenfullyexamined,butthisissueisbeing intensivelyexplorednowadays.
Vaspin(visceraladiposetissue-derivedserineproteaseinhibitor)isanoveladipokine,whichhasbeenisolatedfromboththevisceralandsubcutaneouswhite adiposetissuesofobeseandimpairedglucosetolerant subjects [19] .Thepercentageofbodyfatappearsto bethestrongestdeterminantofsubcutaneousvaspin expression.Vaspin,whichimprovesinsulinsensitivity and glucose tolerance, seems to be a compensatory mechanismswitchingintheobesityassociatedwith insulin resistance [19, 20] . Additionally, vaspin has beenfoundtodown-regulatetheexpressionofprofibrogenicandproinflammatoryagentssuchasleptin, tumournecrosisfactorα(TNF-α),andresistin [21] . On the other hand, serum vaspin in HCC patients was positively associated with intensity of hepatic angiogenesis. Angiogenesis is a phenomenon which aggravates chronic liver disease progression and is observed in the very early stages of NAFLD independentlyofNASH [22, 23] .
TheaimofthisstudywastoassessvaspinmRNA levelsinthelivertissueanditsassociationwithlaboratory parameters, histopathological features, and metabolic abnormalities in morbidly obese women withNAFLD.
Material and methods

Patient selection and serological assays
Fifty-six consecutive severely obese women who underwent bariatric surgery in the time period between2015and2016wereincluded.Allthefemale patients were qualified for the study in cooperation withtheGynaecologicalDepartment,wherethepatientshadbeenassessedinanepidemiologicalstudy regardingtheprevalenceofobesityintheregionof Upper Silesia and had then been proposed bariatric surgery. 
Liver histology
Allincludedpatientsunderwentawedgeliverbiopsy,fromtheleftliverlobe,performedduringbariatricprocedure.Itiswellknownthatassessingliver fibrosis at a distance of < 5 mm from the capsule may give inadequate results, overestimating fibrosis. Therefore, all liver specimens for the histology weretakenrepetitivelywiththefollowingprocedure -withlaparoscopicscissors(noenergyusage)aliver fragment with its capsule were resected to 1 cm depth. Then from the exposed parenchyma a 7 × 7-mm liver fragment was excised (the same tools wereused).Everybariatricprocedurewasstartedby receivingtheliverbiopsy.Thereweretworeasonsfor the above routine: the first one, liver cells inflammatoryfactorexclusioncausedbythesurgeryitself ("surgicalhepatitis");andthesecondone,havingthe abilitytoevaluatethehaemostasisgradeinplaceof biopsy towards the end of the bariatric procedure. Tissue samples were immediately divided into two parts: the first one for routine histopathological examination;andsecondonewasstabilisedinRNAlater (Sigma-Aldrich,St.Louis,USA)andfrozenat−80°C for further molecular procedures. The liver biopsy samples for routine histological examination were stainedwithhaematoxylinandeosin,theazanmethodwasusedforcollagenfibres,andtheywereexamined by two independent experienced pathologists. 
BMI -body mass index; WC -waist circumference; HGB -haemoglobin; WBC -white blood cells; PLT -platelets; ALT -alanine aminotransferase; AST -aspartate aminotransferase; GGTP -gamma-glutamyl transpeptidase; TP -total protein; CRP -C-reactive protein; TSH -thyroid-stimulating hormone; fT 4 -thyroxine; HOMA-IR -homeostatic model assessment for insulin resistance; NS -non-significant
HistopathologicalevaluationwascarriedoutaccordingtoKleiner'sscoringscale [24] .
mRNA vaspin expression in liver tissue
Total RNA was isolated from biopsy specimens using the RNeasy Mini Kit (Qiagen, Hilden, Germany). In addition to the standard procedure, RNase Free DNase Set (Qiagen, Hilden, Germany) was used to remove trace amounts of genomic DNA.RNAwasquantifiedbymeasuringtheabsorbanceat260and280nm(NanoDrop1000Spectro-photometer,ThermoFisherScientific,Wilmington, USA),andtheintegritywasassessedbyelectrophoresisin1.2%agarosegelethidiumbromidestained. RNA isolates were used for cDNA synthesis with reverse transcription method using High Capacity RNA -to cDNA Kit (Applied Biosystems, Foster City,USA)accordingtothemanufacturers'instructions.ReceivedcDNAwasusedtodeterminevaspin gene expression level by real-time quantitative PCR (RT-Q-PCR) assay (TaqMan system). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) wasusedasahousekeepinggene.TaqManprimers andprobeforvaspinandGAPDHwereboughtas ready-to-use assays: vaspin and human GAPD endogenous control (FAM/MGB Probe, Nonprimer Limited) for GAPDH (Applied Biosystems, Foster City, USA). RT-Q-PCRs were performed in duplicateonanABIPRISM7300RealTimePCRDetec-tionSystem(AppliedBiosystems,FosterCity,USA), includingnegativecontrolinallamplificationreactions.Thermalcyclingforbothanalysedgenesand GAPDH was initiated with an incubation step at 50°Cfor2min,followedbyafirstdenaturationstep at 95°C for 10min, and continued with 40 cycles of95°Cfor15sand60°Cfor1min.Thestandard curves for a housekeeping gene GAPDH and the target genes were generated by serial dilutions of thecontrolcDNA(equivalentto1µgoftotalRNA) in four two-fold dilution steps. The vaspin expression levels were determined in every sample from the respective standard curve and divided by the GAPDH gene expression to obtain a normalised targetvalue(relativeexpressionlevel).
Statistical analysis
The results were presented as the mean values with standard deviation (±SD). The distribution of thevalueswasassessedusingShapiro-Wilktest.Due toabnormaldistributionofthevalues,nonparametric methods were used for calculation. Differences betweengroupsweretestedusingUMann-Whitney andANOVArangKruskal-Wallistestsforindependent groups. The Spearman rank correlation coefficient was used to calculate the correlation between differentvalues.P<0.05wasconsideredtobesta-tisticallysignificant.ThesoftwareSTATISTICA12.5 fromStatSoftwasusedtoperformtheanalysis.
Results
Demographic and clinical data
Demographicandclinicaldataofallsubjectsare presentedinTableI.Thestudyincluded18women withBMI<40kg/m 2 and38withBMI≥40kg/m 2 . There were significantly higher ALT, AST, and gamma-glutamyl transpeptidase (GGTP) activities (p=0.04;p=0.04;p=0.001,respectively)and increasedinsulinconcentration(p=0.04)inpatients withhigherBMI.TherewerenodifferencesinglucoseconcentrationandHOMA-IRlevelbetweenpatientswithvariousBMIs.However,HOMA-IRlevelwasabove 3inallanalysedpatients,andonlyin 15patientsitwaslessthan4.Thedetailedcomparison between patients with different BMI is shown alsoinTableI.
Histological examination
The results of histopathological examination are shown in Table II 
Association between other assessed parameters
There were significantly higher levels of glucose, insulin, and HOMA-IR when comparing patients with and without fibrosis (p = 0.007; p = 0.04; p=0.004,respectively)(TableIV).Higherglucose levels were found in patients with lobular inflammation (p = 0.006). Higher levels of insulin and HOMA-IR were revealed in patients with steatosis (p=0.003;p=0.005,respectively).APRIseemed to be a surrogate marker to differentiate severely obesepatientswithandwithoutfibrosis(0.21±0.02 vs.0.37±0.04,respectively,p=0.005),despitethe fact that our analysed group did not included patientswithadvancedfibrosis.
Hepatocyte ballooning was positively associated withlobularinflammation(r=0.54,p<0.001)and steatosisgrade(r=0.57,p<0.001).
Body weight was positively associated with ALT (r=0. 38 
Discussion
Generally,adipokinescanbeclassified,according to their impact on chronic liver disease, into those havingpositiveandnegativeinfluence.ThedataregardingtheroleofsomenoveladipokinesinNAFLD is scarce, especially in morbidly obese patients. It was suggested that different adipokines are in balancewhenadiposetissueisinnormalrange.However, when adipose tissue expands, the fragile balance tends to be disrupted. As far as we are concerned, thisisthefirststudyregardinghepaticvaspinmRNA inmorbidlyobesepatients.Theroleofvaspininthe developmentandprogressionofNAFLDandNASH [26] .ThestudybyAktaset al. revealedserumvaspinlevelstoberaisedinpatients with NAFLD, regardless of potential confounders, and to represent an independent predictor of liver fibrosis [27] .However,thesedifferencesdidnotremain robust after adjustment for BMI or waist circumference [27] .ThemostrecentstudybyPolyzos et al.revealedlowercirculatingvaspininNASHpatientsthanincontrols [28] . OurstudyrevealedthatvaspinmRNAwasfound inliverspecimensofallanalysedpatients.SomeauthorssuggestthattheinductionofvaspinmRNAin humanadiposetissuecouldserveasacompensatory mechanismassociatedwithobesityandsevereIR [26, 29] .ThedatawithrespecttohepaticvaspinmRNA anditsrelationshipwithIRislacking.Ourstudydid not disclose a significant relationship between hepatic vaspin expression and HOMA-IR. However, allthepatientsincludedinourstudyhadabnormal HOMA-IR levels. None of the patients had HO-MA-IRlessthan3,suggestingtheoccurrenceofIR inallmorbidlyobesepatientsincludedinourstudy. To better analyse the relationship between insulin sensitivityandhepaticvaspinmRNAlevels,patients were divided into two subgroups: with HOMA-IR lessthanandabove4,andsubsequentlylessthanand above 5. Unfortunately, there was no difference in hepaticvaspinmRNA.Theexplanationofobtained resultsmaybeduetothefact,asdescribedpreviously,thatIRinducesvaspinexpressiononlyinadipose tissue. The other explanation is the possibility that vaspin mRNA synthesis is evidently up-regulated whenIRappears,anditsincreaseisnotproportional tofurtherIRup-regulation.Asmentionedabove,all thepatientsanalysedinourstudyhadIR.
SteatosisisahallmarkofNAFLD.Macrovesicular or mixed steatosis was observed in all included patients. However, in 17 patients it affected less than 5% of hepatocytes. Steatosis was positively related tofibrosisstageandIR.HOMA-IRwassignificantly higherinpatientswithgrade0thanintherestofthe patients.Moreover,thedifferencewasstillsignificant comparingpatientswithgrade0and1tothosewith grade2and3ofsteatosis.Similarly,analysisofmRNA vaspinlevelsinthelivertissueshowedamarkeddifference with the higher intensity in patients with lipidstorageaffectingmorethan5%ofhepatocytes. Additionalanalysisrevealedfurtherincreaseofvaspin mRNA in patients with greater extent of steatosis, but the difference did not reach statistical significance.Theseresultsareinaccordancewithfindings of our previous studies regarding vaspin serum lev- The next histopathological feature included into thescoringsystemfordiagnosisofNASHishepatocyteballooning [31] .Inourstudy,itsgradewasassociatedwithgradeoflobularinflammationandsteatosis.OurpreviousstudyinCHCpatientsshowed anegativerelationshipbetweenhepatocyteballooningandserumvaspinlevels [30] .Incontrast,inNA-FLD serum vaspin levels were positively associated withhepatocyteballooning [27] .However,themost recentstudydidnotfindsucharelationship [28] .
Ongoing inflammatory process results in developmentofNASHandprogressionoffibrosis.Vaspin hasanti-inflammatoryactivityinhibitingpro-inflammatorycytokinesandadipokines.Surprisingly,inour study vaspin was markedly higher in patients with lobularinflammation.Alterationsofsynthesisofsome adipokinesandsecretionduringexpansionofadipose tissue are compensatory mechanisms to neutralise the negative effects of up-regulated harmful factors. Lobular inflammation, steatosis, and hepatocyte ballooningarehallmarksofNASH.Allthreefeaturesare componentsofNASandmustcoexistfordiagnosisof NASHbasedonhistopathologicalpattern.Pointingto theobtainedresults,revealinganevidentincreaseof vaspinmRNAlevelsinpatientswithlobularinflammation,hepatocyteballooning,andgreaterextentof steatosis, as expected the NAS score was also associatedwithvaspinmRNAlevels.Asmentionedabove, the diagnosis of definite NASH based on evaluation ofhistologicalhallmarks(steatosis,inflammation,and hepatocellular ballooning) on liver biopsies does not always correlate with threshold values of the semiquantitativeNAS.AlthoughNASandthediagnostic systembasedonhistologicalpatternsarecloselycorrelated,theyalsohavedistinctclinicalandpathologicalrelationships [32] .Toavoidthepotentialinfluence of different diagnostic procedure on our results, we investigated both diagnostic arrangements. In both casesthemostevidentup-regulationofvaspin mRNA levelswasobservedinpatientswithdefiniteNASH.
NASH development is strictly associated with fibrosis progression. Our study revealed markedly higher vaspin mRNA in patients with fibrosis. Unfortunately,ourstudydidnotincludepatientswith advancedfibrosisandcirrhosisandonlyasmallgroup ofpatientswithsignificantfibrosis. Data regarding the relationship between serum vaspinandfibrosisinNAFLDisequivocal.Thestudy by Aktas et al. showed positive association between serum vaspin and fibrosis stage. After stepwise linear regression analysis, serum vaspin concentration was the only independent predictor of liver fibrosis in patients with NAFLD. Serum vaspin levels were up-regulated in NAFLD patients regardless of potentialconfounders [27] .Ourpreviousstudyandthe studybyGencet al.didnotfindanyrelationshipbetweenserumvaspinandfibrosisstageinnon-severely obeseNAFLDpatients [25, 26] .However,ourstudy in CHC patients showed vaspin serum levels to be significantly higher in patients with significant and advanced fibrosis. Nonetheless, in patients without fibrosis and with insignificant fibrosis vaspin serum levels were significantly lower. An evident increase invaspinlevelswasobservedinpatientswithatleast periportalfibrosis(stage2),withnofurtherincrease inpatientswithadvancedfibrosis.Thenextintriguing aspect was the fact that serum vaspin levels in patientswithadvancedfibrosiswassimilartothosein thecontrolgroup [33] .Althoughitsimproperclearancebyimpairedliveror/andacompensatoryincrease havingaprotectiveeffectdirectedagainstfurtherliver injury and fibrosis progression could be possible explanations, a potential negative action of vaspin when NAFLD progresses to more advanced stages withfibrosismaynotbeexcluded.Thispresumption is based on the fact that vaspin inhibits expression of profibrogenic factors such as leptin, TNF-α, and resistin [21] .Nevertheless,whenfibrosiswasestablished vaspin serum levels were not associated with itsseverityassessedaccordingChild-PughandModel ofEnd-StageLiverDisease(MELD)scores [34] .Itis wellknownthatIRisanimportantriskfactoroffibrosisprogressioninchronicliverdiseases,including NAFLD [4, 12, 35, 36, 37] .Inourstudy,HOMA-IR was significantly associated with fibrosis stage supportingearlierfindings.Inthecurrentstudy,hepatic vaspinmRNAexpressionwashigherinpatientswith fibrosis,butthedifferencedidnotreachstatisticalsignificance.Unfortunately,significantfibrosis(stage2) was observed only in 16% of patients. Moreover, therewerenopatientswithbridgingfibrosisorcirrhosis.Thissmallnumberofpatientswithsignificant and the lack of those with advanced fibrosis in our groupmayinfluencetheobtainedresults.
This study has some limitations. First, the analysedgroupofpatientsisrelativelysmall.Second,the study included patients without advanced fibrosis andcirrhosis.Third,therewasnopossibilitytocomparetheobtainedresultsinmorbidlyobesepatients with overweight and obese subjects with NAFLD andhealthycontrols.Fourth,thestudyhasanobservationalnature.Fifth,therewasnopossibilitytoassessvaspinmRNAsynthesisinadiposetissue,which issuggestedtobethemainsourceofsystemicvaspin. Sixth,thedifferenceofmeansbetweenmoreandless advancedstateswasevidentbutstatisticallyinsignificant,probablyduetothelargestatisticaldispersion ofthevaluesofvaspinmRNAlevels.Thisphenomenonindicatesthattheexpressionofvaspingenecould beverydiversifiedindifferentsubjectsanddepends notonlyontheamountofadiposetissueandBMI. Seventh,thestudyincludedonlyfemalepatientsand theresultsshouldnotbeextrapolatedtoallpatients. Finally,eighth,wedgeliverbiopsywasperformedin allanalysedpatients.Aswasmentionedabove,itis wellknownthatassessingliverfibrosisatadistance of<5mmfromthecapsule,whencomparedtoneedleliverbiopsy,maygiveinadequateresults,overestimatingfibrosis.However,tominimisethepotential negative influence of overestimated fibrosis on the obtainedresults,allthespecimenswereresectedto1 cmdepth,withanexcisedfragmentof7×7mmfor furtherevaluation.
MostalterationsofadipokinesduringtheexpansionofadiposetissueandexacerbationofIRseemto compensatoryanddirectedtoretainaproperbalance ortoeliminateanegativeeffectexertedbyotherfactors. It seems that adipokines are in balance when adipose tissue is in normal range. However, when adiposetissueexpandsthebalancetendstobelost. Atthebeginning,compensatorymechanismsmaybe successful and efficient to maintain insulin sensitivity and to dam hepatic steatosis and progression to NASH. Unfortunately, when adipose tissue continuestoextend,vaspinalterationmaybemoreharmful than beneficial. These suggestions may be supportedbythestudybyAuguetet al.,whofoundvaspin mRNAlevelstobesignificantlyhigherinbothvisceral and subcutaneous adipose tissue in morbidly obese compared to healthy lean women, but there wasnodifferenceinserumvaspinlevels [38] .Additionally,hepaticvaspinexpressionmaynotcorrelate with its systemic levels and may be associated with paracrineorautocrineactionintheliver.
In conclusion, we may infer from our study that adiposity is an undoubted confounding factor influencing serum vaspin levels. Also, hepatic vaspin geneexpressionseemstobeassociatedwithadipose tissueextent.VaspinmRNAlevelsintheliverseem to be markedly elevated in morbidly obese patients withmoreadvancedNAFLDandwhenhallmarksof NASH were observed. Vaspin may be a compensatory factor in IR and fibrosis. Pointing to non-linearmRNAexpressionwithintheNAFLDspectrum andtheevidentincreaseinpatientswithfibrosisand definiteNASH,adetrimentalactionofvaspincannot be excluded. Prospective cohort studies in men and womenwithpairedbiopsieswouldfacilitatetheassessment of the pathophysiologic interplay between vaspinandNAFLDprogressionovertime.
